Loading news...
BENSALEM, Pa., March 6, 2026 /PRNewswire/ -- The Law Offices of Howard G.
LOS ANGELES, March 6, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bath & Body Works, Inc. ("Bath & Body Works" or "the Company") (NYSE: BBWI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 4, 2024 and November 19, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before March 16, 2026.
LOS ANGELES, March 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Bath & Body Works, Inc. ("Bath & Body Works " or "the Company") (NYSE: BBWI ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of BBWI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bath & Body Works, Inc. (NYSE: BBWI) between June 4, 2024 and November 19, 2025, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead plaintiff deadline.
NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Bath & Body Works beats Q4 estimates despite a sales dip, while advancing its Consumer First Formula to support innovation and long-term growth.
Bath & Body Works, Inc. (NYSE: BBWI) on Wednesday posted upbeat sales for the fourth quarter.
LOS ANGELES, March 5, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI) have opportunity to lead the securities fraud class action lawsuit.
LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bath & Body Works, Inc. (“Bath & Body Works” or “the Company”) (NYSE: BBWI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 4, 2024 and November 19, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 16, 2026.
Bath & Body Works Shareholders Between June 4, 2024 and November 19, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
Bath & Body Works is upgraded to Strong Buy after a robust Q4 beat and attractive valuation. BBWI generates strong free cash flow, enabling a combined 12.3% yield via dividends and buybacks in 2025, with ongoing balance sheet improvements and cost savings. Management guides for $600M FCF in 2026, with cost savings and a multi-year turnaround underpinning intrinsic value well above the current price.
New York, New York--(Newsfile Corp. - March 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bath & Body Works, Inc. (NYSE: BBWI) between June 4, 2024 and November 19, 2025, both dates inclusive (the "Class Period"), of the important March 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Bath & Body Works securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Bath & Body Works (BBWI) To Contact Him Directly To Discuss Their Options
Bath & Body Works, Inc. (BBWI) Q4 2026 Earnings Call Transcript
New class action for Bath & Body (BBWI) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/13/2026.
BBWI shares rise on a Q4 profit beat despite sliding sales. Management eyes a "Consumer First" reset and Amazon expansion amid cautious 2026.
Although the revenue and EPS for Bath & Body Works (BBWI) give a sense of how its business performed in the quarter ended January 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bath & Body Works Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Bath & Body Works between June 4, 2024 and November 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 4, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI) and reminds investors of the March 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Bath & Body Works (BBWI) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $2.09 per share a year ago.
NEW YORK, March 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bath & Body Works, Inc. ("Bath & Body Works, Inc." or the "Company") (NYSE: BBWI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bath & Body Works, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and November 9, 2025.